135 related articles for article (PubMed ID: 25532013)
1. Assessment of active mucosal inflammation in IBD patients in clinical remission.
Agilli M; Aydin FN; Cayci T; Kurt YG
J Gastrointestin Liver Dis; 2014 Dec; 23(4):462-3. PubMed ID: 25532013
[No Abstract] [Full Text] [Related]
2. Reply: To PMID 25267955.
Voiosu T
J Gastrointestin Liver Dis; 2014 Dec; 23(4):463. PubMed ID: 25532014
[No Abstract] [Full Text] [Related]
3. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
[TBL] [Abstract][Full Text] [Related]
4. [Faecal calprotectin in inflammatory bowel disease].
Sipponen T; Kolho KL
Duodecim; 2011; 127(24):2631-7. PubMed ID: 22320105
[TBL] [Abstract][Full Text] [Related]
5. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
6. Rectal NO and fecal calprotectin in IBD.
Lundberg JO
Scand J Gastroenterol; 2009; 44(1):128. PubMed ID: 19101857
[No Abstract] [Full Text] [Related]
7. [Faecal calprotectin in inflammatory bowel diseases: review].
Kallel L; Fekih M; Boubaker J; Filali A
Tunis Med; 2011 May; 89(5):425-9. PubMed ID: 21557177
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic power of fecal calprotectin in inflammatory and functional intestinal disorders.
Agilli M; Aydin FN; Gulcan Kurt Y; Cayci T
Scand J Gastroenterol; 2015 Mar; 50(3):376-7. PubMed ID: 25582762
[No Abstract] [Full Text] [Related]
9. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease.
Sipponen T; Kolho KL
Scand J Gastroenterol; 2015 Jan; 50(1):74-80. PubMed ID: 25523558
[TBL] [Abstract][Full Text] [Related]
10. Reply to: Diagnostic power of fecal calprotectin in inflammatory and functional intestinal disorders.
Caviglia GP; Pellicano R; Astegiano M
Scand J Gastroenterol; 2015 May; 50(5):623-4. PubMed ID: 25737251
[No Abstract] [Full Text] [Related]
11. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.
Røseth AG; Aadland E; Grzyb K
Scand J Gastroenterol; 2004 Oct; 39(10):1017-20. PubMed ID: 15513345
[No Abstract] [Full Text] [Related]
12. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
13. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain.
Akbar A; Yiangou Y; Facer P; Brydon WG; Walters JR; Anand P; Ghosh S
Gut; 2010 Jun; 59(6):767-74. PubMed ID: 20551462
[TBL] [Abstract][Full Text] [Related]
14. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease.
Aomatsu T; Imaeda H; Matsumoto K; Kimura E; Yoden A; Tamai H; Fujiyama Y; Mizoguchi E; Andoh A
Aliment Pharmacol Ther; 2011 Oct; 34(8):941-8. PubMed ID: 21848856
[TBL] [Abstract][Full Text] [Related]
15. Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.
Diamanti A; Colistro F; Basso MS; Papadatou B; Francalanci P; Bracci F; Muraca M; Knafelz D; De Angelis P; Castro M
Inflamm Bowel Dis; 2008 Sep; 14(9):1229-35. PubMed ID: 18398894
[TBL] [Abstract][Full Text] [Related]
16. Correspondence: fecal calprotectin and cut-off levels in inflammatory bowel disease.
Kristensen V; Moum B
Scand J Gastroenterol; 2015; 50(9):1183-4. PubMed ID: 25772406
[No Abstract] [Full Text] [Related]
17. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Nielsen AM
Ugeskr Laeger; 2014 Sep; 176(37):. PubMed ID: 25294035
[TBL] [Abstract][Full Text] [Related]
18. The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease.
Targownik LE; Sexton KA; Bernstein MT; Beatie B; Sargent M; Walker JR; Graff LA
Am J Gastroenterol; 2015 Jul; 110(7):1001-12; quiz 1013. PubMed ID: 26077178
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin: controlling the cost of care.
Abraham BP; Sellin JH
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):263-4. PubMed ID: 24055986
[No Abstract] [Full Text] [Related]
20. Faecal Calprotectin: What Does This Mean for the Paediatric Inflammatory Bowel Disease Phenotype?
Ashton JJ; Beattie RM
J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):e115. PubMed ID: 29210923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
